Misdiagnosed hypomanic symptoms in patients with treatment-resistant major depressive disorder in Italy: Results from the improve study

Clinical Practice and Epidemiology in Mental Health

Volumn 10, Issue , 2014, Pages 42-47

  Francesca, Moro Maria ^a   Efisia, Lecca Maria ^a   Alessandra, Ghillani M ^b   Marianna, Alacqua ^b   Giovanni, Carta Mauro ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Active hypomania; Bipolar symptoms; HCL 32; Irritable hypomania; Resistant MDD; Screening

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DIAGNOSTIC ERROR; FEMALE; HUMAN; HYPERTENSION; HYPOMANIA; HYPOMANIA CHECKLIST 32; HYPOTHYROIDISM; IRRITABILITY; ITALY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; PSYCHIATRIC DEPARTMENT; SCREENING; SMOKING; AGED; CONTROLLED STUDY; MIDDLE AGED; TREATMENT RESISTANT DEPRESSION;

EID: 84900841573     PISSN: None     EISSN: 17450179     Source Type: Journal    
DOI: 10.2174/1745017901410010042     Document Type: Article

References (28)

1. Compton WM, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatr 2006; 163: 2141-7.
2. Alonso J, Angermeyer MC, Bernert S, et al. ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 420: 38-46.
3. Olchanski N, McInnis Myers M, Halseth M, et al. The economic burden of treatment-resistant depression. Clin Ther 2013; 35: 512-22.
4. Carta MG, Aguglia E, Bocchetta A, et al. The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy. Clin Pract Epidemiol Ment Health 2010; 6: 94-100
5. Balestrieri M, Carta MG, Leonetti S, Sebastiani G, Starace F, Bellantuono C. Recognition of depression and appropriateness of antidepressant treatment in Italian primary care. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 171-6.
6. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000 J Clin Psychiatr 2003; 64: 1465-75.
7. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2197-223.
8. Warden D, Rush AJ, Trivedi MH, et al. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 2007; 9: 449-59.
9. Halpern JK, Glassman AH. Adequate tricyclic treatment: defining the tricyclic non responder. In: Roose SP, Glassman AH, Eds. Treatment strategies for refractory depression. Washington, DC: American Psychiatric Press 1990; pp. 11-32.
10. Roose SP. Methodological issues in the diagnosis, treatment and study of refractory depression. In: Roose SP, Glassman AH, Eds. Treatment strategies for refractory depression. Washington, DC: American Psychiatric Press 1990; pp. 3-9.
11. Thase ME, Rush AJ. Treatment-resistant depression. In: Blooms FE, Kupfer DJ. Eds. Psychopharmacology: The Fourth Generation of Progress. NY: Raven Press 1995; pp. 1081-97.
12. Dudek D, Rybakowski JK, Siwek M, et al. Risk factors of treatment resistance in major depression: association with bipolarity. J Affect Disord 2010; 126: 268-71.
13. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatr 2003; 64: 53-9.
14. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder. How far have we really come Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatr 2003; 64: 161-74.
15. Carta MG, Angst J. Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveys. Clin Pract Epidemol Ment Health 2005; 1: 4.
16. Fountoulakis KN, Kasper S, Andreassen O, et al. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatr Clin Neurosci 2012; 262 (Suppl 1): 1-48.
17. Ei-Mallakh RS, Karippot A. Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series. J Affect Disord 2005; 84: 267-72.
18. Carta MG, Hardoy MC, Cadeddu M, et al. The accuracy of the Italian version of the Hypomania Checklist (HCL-32) for the screening of bipolar disorders and comparison with the Mood Disorder Questionnaire (MDQ) in a clinical sample. Clin Pract Epidemiol Ment Health 2006; 2: 2.
19. Angst J, Meyer TD, Adolfsson R, et al. Hypomania: a transcultural perspective. World Psychiatr 2010; 9(1): 41-9.
20. Zimmerman M, Galione JN, Ruggero CJ, et al. Performance of the mood disorders questionnaire in a psychiatric outpatient setting. Bipolar Disord 2009; 11: 759-65.
21. Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatr 2011; 68: 241-51.
22. Zimmerman M, Galione JN, Ruggero CJ, et al. Screening for bipolar disorder and finding borderline personality disorder. J Clin Psychiatr 2010; 71(9): 1212-7.
23. Carta MG, Balestrieri M, Murru A, Hardoy MC. Adjustment Disorder: epidemiology, diagnosis and treatment. Clin Pract Epidemiol Ment Health 2009; 5: 15.
24. First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV Axis I Disorders Clinician Version (SCIDCV). Washington DC: American Psychiatric Press 1997.
25. Yang HC, Xiang YT, Liu TB, et al. Hypomanic symptoms assessed by the HCL-32 in patients with major depressive disorder: a multicenter trial across China. J Affect Disord 2012; 143: 203-37.
26. Bschor T, Angst J, Azorin JM, et al. Are bipolar disorders underdiagnosed in patients with depressive episodes Results of the multicenter BRIDGE screening study in Germany. J Affect Disord 2012; 142: 45-52.
27. Hu C, Xiang YT, Ungvari GS, et al. Undiagnosed bipolar disorder in patients treated for major depression in China. J Affect Disord 2012; 140: 181-6.
28. Akiskal HS, Akiskal KK, Lancrenon S, et al. Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes. J Affect Disord 2006; 96: 197-205.